Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Change in Account Payables (2020 - 2026)

Immuneering's Change in Account Payables history spans 7 years, with the latest figure at -$89579.0 for Q1 2026.

  • On a quarterly basis, Change in Account Payables rose 86.98% to -$89579.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $197493.0, a 121.53% increase, with the full-year FY2025 number at -$400799.0, down 257.4% from a year prior.
  • Change in Account Payables came in at -$89579.0 for Q1 2026, down from $73415.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $1.2 million in Q2 2025, with the low at -$974893.0 in Q3 2025.
  • Historically, Change in Account Payables has averaged $2988.2 across 5 years, with a median of $56741.0 in 2024.
  • Biggest five-year swings in Change in Account Payables: crashed 731.07% in 2022 and later skyrocketed 675.42% in 2024.
  • Year by year, Change in Account Payables stood at $816177.0 in 2022, then tumbled by 79.1% to $170568.0 in 2023, then crashed by 66.73% to $56741.0 in 2024, then grew by 29.39% to $73415.0 in 2025, then tumbled by 222.02% to -$89579.0 in 2026.
  • Business Quant data shows Change in Account Payables for IMRX at -$89579.0 in Q1 2026, $73415.0 in Q4 2025, and -$974893.0 in Q3 2025.